Back to Search
LINA CHING, M.D.
M.D.
Rheumatology Physician
NPI: 1689848996IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
57.010688(OH)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
P1627(TX)
Education
OTHER
Class of 2005
Research & Publications (20)
Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene.
PMID 19628018·Mol Cell Endocrinol·2010
8-other
Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404).
PMID 19649209·Neoplasia·2009
7-preclinical
Enhancement of the action of the antivascular drug 5,6-dimethylxanthenone-4-acetic acid (DMXAA; ASA404) by non-steroidal anti-inflammatory drugs.
PMID 18696010·Invest New Drugs·2009
7-preclinical
Inducing gene expression of cardiac antioxidant enzymes by dietary phenolic acids in rats.
PMID 18547798·J Nutr Biochem·2009
7-preclinical
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.
PMID 18987148·J Virol·2009
8-other
Vitamin C enhances phagocytosis of necrotic trophoblasts by endothelial cells and protects the phagocytosing endothelial cells from activation.
PMID 19070894·Placenta·2009
8-other
Strength of commitment language in motivational interviewing and gambling outcomes.
PMID 19290696·Psychol Addict Behav·2009
8-other
A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre-eclampsia.
PMID 18825657·J Pathol·2009
8-other
Regio- and stereoselective biomimetic synthesis of oligostilbenoid dimers from resveratrol analogues: influence of the solvent, oxidant, and substitution.
PMID 19003831·Chemistry·2008
8-other
The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous human immunodeficiency virus type 1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen.
PMID 18003732·J Virol·2008
8-other
Differential effects of neuromuscular blockers on twitches and tetani in the isolated rat muscle: a multiple comparison study using simultaneous confidence intervals.
PMID 18844723·Fundam Clin Pharmacol·2008
4-observational
IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
PMID 18338946·J Interferon Cytokine Res·2008
7-preclinical
Consequences of increased vascular permeability induced by treatment of mice with 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and thalidomide.
PMID 17473922·Cancer Chemother Pharmacol·2008
7-preclinical
The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis.
PMID 17562815·J Exp Med·2007
7-preclinical
Synthesis and biological activity of azido analogues of 5,6-dimethylxanthenone-4-acetic acid for use in photoaffinity labeling.
PMID 17616114·J Med Chem·2007
7-preclinical
Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours.
PMID 16944150·Cancer Chemother Pharmacol·2007
7-preclinical
The vascular disrupting agent, DMXAA, directly activates dendritic cells through a MyD88-independent mechanism and generates antitumor cytotoxic T lymphocytes.
PMID 17638914·Cancer Res·2007
7-preclinical
Inhibition of DMXAA-induced tumor necrosis factor production in murine splenocyte cultures by NF-kappaB inhibitors.
PMID 16783963·Oncol Res·2006
7-preclinical
5,6-Dimethylxanthenone-4-acetic acid treatment of a non-immunogenic tumour does not synergize with active or passive CD8+ T-cell immunotherapy.
PMID 16834573·Immunol Cell Biol·2006
7-preclinical
A comparison of the ability of DMXAA and xanthenone analogues to activate NF-kappaB in murine and human cell lines.
PMID 16491953·Oncol Res·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1331 W GRAND PKWY N STE 150
KATY, TX 77493 - Phone
- (281) 205-8199
Quick Facts
- NPI
- 1689848996
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile